Clinical trial
Bone Loss in Women With Anorexia Nervosa
NCT00089843 · Massachusetts General Hospital, Other · Completed
Key facts
| NCT number | NCT00089843 |
|---|---|
| Title | Bone Loss in Women With Anorexia Nervosa |
| Official title | IGF-1 and Bone Loss in Women Anorexia Nervosa |
| Lead sponsor | Massachusetts General Hospital, Other |
| Collaborators | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) NIH National Center for Research Resources (NCRR) |
| Status | Completed |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | Anorexia Nervosa |
| Intervention type | Drug |
| Interventions | Testosterone, Actonel (risedronate), Placebo Actonel (risedronate), Placebo testosterone |
| Enrollment | 77 |
| Start date | Jun 1, 2003 |
| Primary completion | Apr 1, 2008 |
| Completion | Apr 1, 2008 |
| First posted | Aug 17, 2004 |
| Last update posted | Sep 2, 2020 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: